Quest Diagnostics (DGX) Income from Non-Controlling Interests (2009 - 2026)
Quest Diagnostics (DGX) posted Income from Non-Controlling Interests of $12.0 million for Q1 2026, up 9.09% sequentially from $11.0 million in Q4 2025, and down 20.0% YoY from $15.0 million in Q1 2025.
Quest Diagnostics (DGX) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
Quest Diagnostics (DGX) has 18 years of Income from Non-Controlling Interests data on file, last reported at $12.0 million in Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 20.0% year-over-year to $12.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $54.0 million, up 8.0% from the prior year.
- Income from Non-Controlling Interests climbed to $12.0 million in Q1 2026 per DGX's latest filing, from $11.0 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $20.0 million in Q3 2022, with the low at $11.0 million in Q2 2024.
- Average Income from Non-Controlling Interests over 5 years is $14.1 million, with a median of $14.0 million recorded in 2023.
- Year-over-year, Income from Non-Controlling Interests sank 40.0% in 2023 and gained 27.27% in 2025.
- Quest Diagnostics' Income from Non-Controlling Interests stood at $15.0 million in 2022, then fell by 13.33% to $13.0 million in 2023, then gained by 7.69% to $14.0 million in 2024, then dropped by 21.43% to $11.0 million in 2025, then rose by 9.09% to $12.0 million in 2026.
- Business Quant data shows DGX's Income from Non-Controlling Interests at $12.0 million in Q1 2026, $11.0 million in Q4 2025, and $14.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 1.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | 12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 11.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 14.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 11.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 13.00 Mn |
| Sep 30, 2023 | 12.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | 15.00 Mn |
| Dec 31, 2022 | 15.00 Mn |
| Sep 30, 2022 | 20.00 Mn |
| Jun 30, 2022 | 16.00 Mn |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 23.00 Mn |
| Sep 30, 2021 | 22.00 Mn |
| Jun 30, 2021 | 19.00 Mn |